CRISPR Therapeutics AG (BKK:CRSP03)

CRISPR Therapeutics AG Statistics

Total Valuation

BKK:CRSP03 has a market cap or net worth of THB 172.62 billion. The enterprise value is 116.31 billion.

Market Cap	172.62B
Enterprise Value	116.31B

Important Dates

The next estimated earnings date is Monday, May 11, 2026.

Earnings Date	May 11, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+6.60%
Shares Change (QoQ)	+4.34%
Owned by Insiders (%)	0.39%
Owned by Institutions (%)	78.40%
Float	95.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1,559.42
PB Ratio	2.85
P/TBV Ratio	2.85
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-6.34
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-10.66

Financial Position

The company has a current ratio of 13.32, with a Debt / Equity ratio of 0.11.

Current Ratio	13.32
Quick Ratio	13.25
Debt / Equity	0.11
Debt / EBITDA	n/a
Debt / FCF	-0.60
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -30.18% and return on invested capital (ROIC) is -312.24%.

Return on Equity (ROE)	-30.18%
Return on Assets (ROA)	-15.76%
Return on Invested Capital (ROIC)	-312.24%
Return on Capital Employed (ROCE)	-26.86%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	281,666
Profits Per Employee	-46.67M
Employee Count	393
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

In the past 12 months, BKK:CRSP03 has paid 114.61 million in taxes.

Income Tax	114.61M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	1,177

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	13.62

Income Statement

In the last 12 months, BKK:CRSP03 had revenue of THB 110.69 million and -18.34 billion in losses. Loss per share was -204.04.

Revenue	110.69M
Gross Profit	-15.60B
Operating Income	-17.92B
Pretax Income	-18.23B
Net Income	-18.34B
EBITDA	-17.31B
EBIT	-17.92B
Loss Per Share	-204.04

Balance Sheet

The company has 62.31 billion in cash and 6.52 billion in debt, with a net cash position of 55.79 billion.

Cash & Cash Equivalents	62.31B
Total Debt	6.52B
Net Cash	55.79B
Net Cash Per Share	n/a
Equity (Book Value)	60.61B
Book Value Per Share	632.03
Working Capital	57.92B

Cash Flow

In the last 12 months, operating cash flow was -10.88 billion and capital expenditures -28.82 million, giving a free cash flow of -10.91 billion.

Operating Cash Flow	-10.88B
Capital Expenditures	-28.82M
Free Cash Flow	-10.91B
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	-16,191.40%
Pretax Margin	-16,466.24%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BKK:CRSP03 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.60%
Shareholder Yield	-6.60%
Earnings Yield	-10.63%
FCF Yield	-6.32%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BKK:CRSP03 has an Altman Z-Score of 6.78 and a Piotroski F-Score of 1.

Altman Z-Score	6.78
Piotroski F-Score	1